Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation, Stock Options and Stock Appreciation Rights Award Activity

The following table presents certain information related to the activity of our non-vested stock option grants:

	Number of Stock Options	Weighted Average Grant Date Fair Value		Weighted Average Exercise Prices
Outstanding as of December 31, 2017	—	$	—	$	—
Granted	29,464	8.01		20.44
Less: Forfeited	—	—		—
Less: Vested	—	—		—
Outstanding as of September 30, 2018	29,464	$	8.01	$	20.44
Exercisable as of September 30, 2018	—	$	—	$	—

Schedule of Nonvested Share Activity

The following table presents certain information related to the activity of our non-vested common stock grants:

	Number of Restricted Shares	Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2017	212,094	$	16.44
Granted	174,602	20.07
Less: Forfeited	17,077	18.07
Less: Vested	139,183	16.38
Outstanding as of September 30, 2018	230,436	$	19.11

Share-based Compensation, Activity [Table Text Block]

The following table presents our total stock-based compensation expense:

	Three Months Ended September 30,				Nine months ended September 30,
	2018		2017		2018		2017
Employee stock-based compensation expense
Pre-tax	$	248	$	393	$	736	$	1,179
Post-tax (1)	196		310		581		931
Director stock-based compensation expense
Pre-tax	379		244		940		752
Post-tax (1)	299		193		743		594

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The following weighted-average assumptions were used to value the stock options granted:

	2018
Expected annual dividend yield	1.17	%
Expected volatility	41.31	%
Risk-free interest rate	2.98	%
Expected term	6	years